News

ISTAT. Pharmaceutical export trend change in April +39.1%

In April 2019, economic growth is estimated for both foreign trade flows, more intense for imports (+0.9%) than for exports (+0.3%). The cyclical increase in exports can be ascribed to the increase in sales both to non-EU markets (+0.4%) and to the EU area (+0.2%).

In the February-April 2019 quarter, compared to the previous one, there was a modest increase in exports (+0.4%) and a more marked decrease in imports (-1.3%).

In April 2019, the growth in exports on an annual basis was +5.8% and is determined by the increase in sales recorded both for the non-EU area (+6.7%) and for the EU (+5.2%) . Similarly, imports are on the rise (+6.7%) both from non-EU markets (+7.4%) and from the EU area (+6.1%).

Among the sectors that contribute positively to trend change in exports in April 2019, of note are pharmaceutical, chemical-medicinal and botanical items (+39.1%), food products, beverages and tobacco (+13.3%) and machinery and appliances nec (+4.8%). Motor vehicles (-10.2%) and refined petroleum products (-12.5%) decreased on an annual basis.

On an annual basis, the countries that contribute most to the increase in exports are Switzerland (+24.8%), the United States (+6.1%), France (+3.9%) and Germany (+3.0%) while a decrease in sales to Turkey (-15.5%) and OPEC countries (-5.1%).

In the first four months of 2019, the year-on-year increase in exports (+2.9%) was mainly driven by sales of textiles and clothing, leather and accessories (+7.2%), base metals and products metal, excluding machinery and equipment (+4.4%), food, beverage and tobacco products (+8.0%) and pharmaceutical, chemical-medicinal and botanical items (+20.5%).

It is estimated that the trade surplus will decrease by 101 million euros (from +2,985 million in April 2018 to +2,885 million in April 2019). In the first four months of the year the trade surplus reaches +11,027 million (+24,718 million net of energy products).

In April 2019, a slight cyclical growth in import prices is estimated (+0.5%); on an annual basis, the increase is equal to 1.2%.

FULL TEXT AND METHODOLOGICAL NOTE

ISTAT – 19 June 2019

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco